InsidersTradesSigma
Browse the detailed record of transactions filed by Shah Amit B., Chief Financial Officer. Insider active across 1 companies, notably Oncotelic Therapeutics, Inc.. In total, 2 reports have been logged. The latest transaction was filed on 8 July 2021 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Amit B. Shah serves as the Chief Financial Officer at Oncotelic Therapeutics, Inc. He oversees the company's financial management, including budgeting and risk management. Shah brings expertise in finance and accounting, contributing to strategic decisions that promote Oncotelic's growth and sustainability. His commitment to financial transparency enhances trust among investors and stakeholders.